Sanofi’s dupixent approved in the US as the first-ever biologic medicine for patients with COPD
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
This initiative aims to raise awareness about the importance of monitoring blood sugar levels before indulging in sweets
The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
This license will enable Abbott to enhance access to this novel therapy to more patients across India
Stable profits, low leverage to keep credit profiles comfortable
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
MoU signed to drive digital transformation through strategic projects across all three business sectors of Merck
Subscribe To Our Newsletter & Stay Updated